AIMS/HYPOTHESIS: Enterovirus infections are among the environmental risk factors potentially contributing to the pathogenesis of Type 1 diabetes. The aim of this study was to evaluate virus-host interaction by analysing the enterovirus antibody levels in subjects carrying different HLA-DR alleles associated with either increased or decreased risk of Type 1 diabetes. METHODS: Antibodies against coxsackievirus B4 were measured to study immune responses induced by natural enterovirus infections and against poliovirus 1 to study immune responses induced by immunisation by enterovirus antigens (vaccine). Antibodies against the mumps virus were measured as a control. Study subjects included siblings of children with Type 1 diabetes taking part in the Childhood Diabetes in Finland (DiMe) Study and carrying either HLA-DR risk (DR3 and/or DR4) or protective (DR2) alleles. RESULTS: Children with either the HLA-DR3 or HLA-DR4 allele and those with both these risk alleles had higher Coxsackie B4 antibody levels than children carrying the HLA-DR2 allele ( p=0.01, p=0.01 and p=0.008, respectively). High responders (IgG levels higher than 75 percent) were also more frequent among genetically susceptible children compared to children with the protective DR2 allele (27% vs 12%) ( p<0.009). The same trend was seen for poliovirus antibodies, while mumps antibody levels had a different pattern (high responders more common among DR2-positive subjects). CONCLUSIONS/ INTERPRETATION: Diabetes-associated HLA-DR risk alleles were associated with a strong immune responsiveness and protective alleles with a weak responsiveness against enterovirus antigens. This phenomenon should be taken into consideration in serological case-control studies and it might play a role in virus-induced beta-cell damage.
AIMS/HYPOTHESIS: Enterovirus infections are among the environmental risk factors potentially contributing to the pathogenesis of Type 1 diabetes. The aim of this study was to evaluate virus-host interaction by analysing the enterovirus antibody levels in subjects carrying different HLA-DR alleles associated with either increased or decreased risk of Type 1 diabetes. METHODS: Antibodies against coxsackievirus B4 were measured to study immune responses induced by natural enterovirus infections and against poliovirus 1 to study immune responses induced by immunisation by enterovirus antigens (vaccine). Antibodies against the mumps virus were measured as a control. Study subjects included siblings of children with Type 1 diabetes taking part in the Childhood Diabetes in Finland (DiMe) Study and carrying either HLA-DR risk (DR3 and/or DR4) or protective (DR2) alleles. RESULTS:Children with either the HLA-DR3 or HLA-DR4 allele and those with both these risk alleles had higher Coxsackie B4 antibody levels than children carrying the HLA-DR2 allele ( p=0.01, p=0.01 and p=0.008, respectively). High responders (IgG levels higher than 75 percent) were also more frequent among genetically susceptible children compared to children with the protective DR2 allele (27% vs 12%) ( p<0.009). The same trend was seen for poliovirus antibodies, while mumps antibody levels had a different pattern (high responders more common among DR2-positive subjects). CONCLUSIONS/ INTERPRETATION:Diabetes-associated HLA-DR risk alleles were associated with a strong immune responsiveness and protective alleles with a weak responsiveness against enterovirus antigens. This phenomenon should be taken into consideration in serological case-control studies and it might play a role in virus-induced beta-cell damage.
Authors: H Peltola; V Karanko; T Kurki; V Hukkanen; M Virtanen; K Penttinen; M Nissinen; O P Heinonen Journal: Lancet Date: 1986-01-18 Impact factor: 79.321
Authors: M Lönnrot; K Korpela; M Knip; J Ilonen; O Simell; S Korhonen; K Savola; P Muona; T Simell; P Koskela; H Hyöty Journal: Diabetes Date: 2000-08 Impact factor: 9.461
Authors: J Tuomilehto; R Lounamaa; E Tuomilehto-Wolf; A Reunanen; E Virtala; E A Kaprio; H K Akerblom Journal: Diabetologia Date: 1992-01 Impact factor: 10.122
Authors: Hanna Honkanen; Sami Oikarinen; Noora Nurminen; Olli H Laitinen; Heini Huhtala; Jussi Lehtonen; Tanja Ruokoranta; Minna M Hankaniemi; Valérie Lecouturier; Jeffrey W Almond; Sisko Tauriainen; Olli Simell; Jorma Ilonen; Riitta Veijola; Hanna Viskari; Mikael Knip; Heikki Hyöty Journal: Diabetologia Date: 2017-01-09 Impact factor: 10.122
Authors: Ondrej Cinek; Lars C Stene; Lenka Kramna; German Tapia; Sami Oikarinen; Elisabet Witsø; Trond Rasmussen; Peter A Torjesen; Heikki Hyöty; Kjersti S Rønningen Journal: Diabetologia Date: 2014-07-23 Impact factor: 10.122
Authors: H Viskari; J Ludvigsson; R Uibo; L Salur; D Marciulionyte; R Hermann; G Soltesz; M Füchtenbusch; A-G Ziegler; A Kondrashova; A Romanov; B Kaplan; Z Laron; P Koskela; T Vesikari; H Huhtala; M Knip; H Hyöty Journal: Diabetologia Date: 2005-05-19 Impact factor: 10.122
Authors: Kristian F Lynch; Hye-Seung Lee; Carina Törn; Kendra Vehik; Jeffrey P Krischer; Helena Elding Larsson; Michael J Haller; William A Hagopian; Marian J Rewers; Jin-Xiong She; Olli G Simell; Jorma Toppari; Anette-G Ziegler; Beena Akolkar; Heikki Hyöty; Ezio Bonifacio; Åke Lernmark Journal: J Autoimmun Date: 2017-09-21 Impact factor: 14.511
Authors: Hanna Viskari; Mikael Knip; Sisko Tauriainen; Heini Huhtala; Riitta Veijola; Jorma Ilonen; Olli Simell; Heljä-Marja Surcel; Heikki Hyöty Journal: Diabetes Care Date: 2012-03-19 Impact factor: 19.112
Authors: Maria Elfving; Johan Svensson; Sami Oikarinen; Björn Jonsson; Per Olofsson; Göran Sundkvist; Bengt Lindberg; Ake Lernmark; Heikki Hyöty; Sten-Anders Ivarsson Journal: Exp Diabetes Res Date: 2008